Literature DB >> 26224361

Transient suppression of hepatocellular replication in the mouse liver following transduction with recombinant adeno-associated virus.

A P Dane1,2, S C Cunningham1, C Y Kok1, G J Logan1, I E Alexander1,3.   

Abstract

Recombinant vectors based on adeno-associated virus (AAV) are proving to be powerful tools for genetic manipulation of the liver, for both discovery and therapeutic purposes. The system can be used to deliver transgene cassettes for expression or, alternatively, DNA templates for genome editing via homologous recombination. The replicative state of target cells is known to influence the efficiency of these processes and knowledge of the host-vector interactions involved is required for optimally effective vector deployment. Here we show, for the first time in vivo, that in addition to the known effects of hepatocellular replication on AAV-mediated gene transfer, the vector itself exerts a potent, albeit transient suppressive effect on cell cycle progression that is relieved on a time course that correlates with the known rate of clearance of input single-stranded vector DNA. This finding requires further mechanistic investigation, delineates an excellent model system for such studies and further deepens our insight into the complexity of interactions between AAV vectors and the cell cycle in a clinically promising target tissue.

Entities:  

Mesh:

Year:  2015        PMID: 26224361     DOI: 10.1038/gt.2015.66

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  31 in total

1.  Efficient neuronal gene transfer with AAV8 leads to neurotoxic levels of tau or green fluorescent proteins.

Authors:  Ronald L Klein; Robert D Dayton; Nancy J Leidenheimer; Karen Jansen; Todd E Golde; Richard M Zweig
Journal:  Mol Ther       Date:  2005-12-01       Impact factor: 11.454

2.  Sexually dimorphic patterns of episomal rAAV genome persistence in the adult mouse liver and correlation with hepatocellular proliferation.

Authors:  Allison P Dane; Sharon C Cunningham; Nicole S Graf; Ian E Alexander
Journal:  Mol Ther       Date:  2009-06-30       Impact factor: 11.454

3.  Long-term safety and efficacy following systemic administration of a self-complementary AAV vector encoding human FIX pseudotyped with serotype 5 and 8 capsid proteins.

Authors:  Amit C Nathwani; Cecilia Rosales; Jenny McIntosh; Ghasem Rastegarlari; Devhrut Nathwani; Deepak Raj; Sushmita Nawathe; Simon N Waddington; Roderick Bronson; Scott Jackson; Robert E Donahue; Katherine A High; Federico Mingozzi; Catherine Y C Ng; Junfang Zhou; Yunyu Spence; M Beth McCarville; Marc Valentine; James Allay; John Coleman; Susan Sleep; John T Gray; Arthur W Nienhuis; Andrew M Davidoff
Journal:  Mol Ther       Date:  2011-01-18       Impact factor: 11.454

4.  Insight into the mechanism of inhibition of adeno-associated virus by the Mre11/Rad50/Nbs1 complex.

Authors:  Thomas B Lentz; R Jude Samulski
Journal:  J Virol       Date:  2014-10-15       Impact factor: 5.103

Review 5.  Aneuploidy, polyploidy and ploidy reversal in the liver.

Authors:  Andrew W Duncan
Journal:  Semin Cell Dev Biol       Date:  2013-01-16       Impact factor: 7.727

6.  Gene delivery to the juvenile mouse liver using AAV2/8 vectors.

Authors:  Sharon C Cunningham; Allison P Dane; Afroditi Spinoulas; Grant J Logan; Ian E Alexander
Journal:  Mol Ther       Date:  2008-04-15       Impact factor: 11.454

7.  Image analysis of bromodeoxyuridine (BrdU) staining for measurement of S-phase in rat and mouse liver.

Authors:  A R Soames; D Lavender; J R Foster; S M Williams; E B Wheeldon
Journal:  J Histochem Cytochem       Date:  1994-07       Impact factor: 2.479

8.  Multiyear therapeutic benefit of AAV serotypes 2, 6, and 8 delivering factor VIII to hemophilia A mice and dogs.

Authors:  Haiyan Jiang; David Lillicrap; Susannah Patarroyo-White; Tongyao Liu; Xiaobing Qian; Ciaran D Scallan; Sandra Powell; Tracey Keller; Morag McMurray; Andrea Labelle; Dea Nagy; Joseph A Vargas; Shangzhen Zhou; Linda B Couto; Glenn F Pierce
Journal:  Blood       Date:  2006-03-07       Impact factor: 22.113

9.  Cell proliferation and renewal of normal hepatocytes and bile duct cells in adult mouse liver.

Authors:  Yasushi Magami; Takeshi Azuma; Hideto Inokuchi; Shinichiro Kokuno; Fuminori Moriyasu; Keiichi Kawai; Takanori Hattori
Journal:  Liver       Date:  2002-10

10.  Promoterless gene targeting without nucleases ameliorates haemophilia B in mice.

Authors:  A Barzel; N K Paulk; Y Shi; Y Huang; K Chu; F Zhang; P N Valdmanis; L P Spector; M H Porteus; K M Gaensler; M A Kay
Journal:  Nature       Date:  2014-10-29       Impact factor: 49.962

View more
  1 in total

1.  Efficient in vivo editing of OTC-deficient patient-derived primary human hepatocytes.

Authors:  Samantha L Ginn; Anais K Amaya; Sophia H Y Liao; Erhua Zhu; Sharon C Cunningham; Michael Lee; Claus V Hallwirth; Grant J Logan; Szun S Tay; Anthony J Cesare; Hilda A Pickett; Markus Grompe; Kimberley Dilworth; Leszek Lisowski; Ian E Alexander
Journal:  JHEP Rep       Date:  2019-12-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.